Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate

INTRODUCTION: Vitamin K antagonists (VKA) and non‐vitamin K oral antagonist anticoagulants (NOAC) are used in the clinic to reduce risk of thrombosis. However, they also exhibit vascular off‐target effects. The aim of this study is to compare VKA and NOAC on atherosclerosis progression and calcifica...

Descripción completa

Detalles Bibliográficos
Autores principales: van Gorp, Rick H., Dijkgraaf, Ingrid, Bröker, Vanessa, Bauwens, Matthias, Leenders, Peter, Jennen, Danyel, Dweck, Marc R., Bucerius, Jan, Briedé, Jacco J., van Ryn, Joanne, Brandenburg, Vincent, Mottaghy, Felix, Spronk, Henri M. H., Reutelingsperger, Chris P., Schurgers, Leon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
VASCULAR BIOLOGY
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252511/
https://www.ncbi.nlm.nih.gov/pubmed/33687782
http://dx.doi.org/10.1111/jth.15289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252511/
https://www.ncbi.nlm.nih.gov/pubmed/33687782
http://dx.doi.org/10.1111/jth.15289

Ejemplares similares